Abstract:Background: Enhancing white adipose tissue (WAT) browning combats obesity. The RII(3 subunit of cAMP-dependent protein kinase (PKA) is primarily expressed in the brain and adipose tissue. Deletion of the hypothalamic RII(3 gene centrally induces WAT browning, yet the peripheral mechanisms mediating this process remain unexplored. Methods: This study investigates the mechanisms underlying WAT browning in RII(3-KO mice. Genetic approaches such as (33-adrenergic receptors ((33ARs) deletion and sympathetic denervation of WAT were utilized. Genome-wide transcriptomic sequencing and bioinformatic analysis were employed to identify potential mediators of WAT browning. siRNA assays were employed to knock down mTOR and lipin1 in vitro, , while AAV-shRNAs were used for the same purpose in vivo. Results: We found that WAT browning substantially contributes to the lean and obesity-resistant phenotypes of RII(3-KO mice. The WAT browning can be dampened by (33ARs 3 ARs deletion or WAT sympathetic denervation. We identified that adipocytic mTOR and lipin1 may act as mediators of the WAT browning. Inhibition of mTOR or lipin1 abrogates WAT browning and hinders the lean phenotype of RII(3-KO mice. In human subcutaneous white adipocytes and mouse white adipocytes, (33AR 3 AR stimulation can activate mTOR and causes lipin1 nuclear translocation; knockdown of mTOR and Lipin1 mitigates WAT browning-associated gene expression, impedes mitochondrial activity. Moreover, mTOR knockdown reduces lipin1 level and nuclear translocation, indicating that lipin1 may act downstream of mTOR. Additionally, in vivo knockdown of mTOR and Lipin1 diminished WAT browning and increased adiposity. Conclusions: The beta 3AR-activated 3 AR-activated mTOR-lipin1 axis mediates WAT browning, offering new insights into the molecular basis of PKA-regulated WAT browning. These findings provide potential adipose target candidates for the development of drugs to treat obesity.

WIP1 phosphatase is a critical regulator of adipogenesis through dephosphorylating PPARγ serine 112

Mice with an Adipocyte-Specific Lipin 1 Separation-of-function Allele Reveal Unexpected Roles for Phosphatidic Acid in Metabolic Regulation

PPA1 Regulates Systemic Insulin Sensitivity by Maintaining Adipocyte Mitochondria Function as a Novel PPARγ Target Gene

Adipocyte-specific PIK3C3/VPS34 controls adipogenesis, metabolically-triggered inflammation, insulin resistance, and adaptive thermogenesis in mice

Protein Tyrosine Phosphatase 1B Inhibits Adipocyte Differentiation and Mediates TNFα Action in Obesity.

The Biological Function and the Regulatory Roles of Wild-Type P53-Induced Phosphatase 1 in Immune System

βAR-mTOR-lipin1 pathway mediates PKA-RIIβ deficiency-induced adipose browning

The Role of Wnt Signalling Pathway in Adipogenesis

An Epistatic Interaction Between Pnpla2 and Lipe Reveals New Pathways of Adipose Tissue Lipolysis

Hepatocyte Nuclear Factor 1b is a Novel Negative Regulator of White Adipocyte Differentiation

Adipose tissue lipolysis is regulated by PAQR11 via altering protein stability of phosphodiesterase 4D

Phosphatase Wip1 is essential for the maturation and homeostasis of medullary thymic epithelial cells in mice.

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis

Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice

The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment to influence gene expression during beige adipogenesis

Phosphatase Wip1 in Immunity: an Overview and Update

PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity

Transcription factor PATZ1 promotes adipogenesis by controlling promoter regulatory loci of adipogenic factors

(3 AR-mTOR-lipin1 Pathway Mediates PKA-RII(3 (3 Deficiency-Induced Adipose Browning

Lack of Adipocyte IP3R1 Reduces Diet-Induced Obesity and Greatly Improves Whole-Body Glucose Homeostasis